Part of: this research — view all 12 rows
"None by 2040" (40%)
The most likely outcome remains that none of these questions is answered by an AI-originated result before 2040, though the probability sits below 50% given the extreme pace of AI capability growth. To qualify, a general-purpose AI system must produce both the central idea and the main result, and biologists must come to accept it. While general systems recently scaled from 5% to 100% on FrontierMath Tier 4 within 18 months, biology operates under very different constraints. Wet-lab rounds still take 1–5 weeks, independent replication is slow—as of October 2026, no AI-originated biology claim has been independently replicated Early progress on accelerating drug development with Claude—and several of these broad questions may never yield a single, consensus answer. Across the cluster, the shared bottleneck is not merely generating breakthroughs but reaching scientific consensus on multi-causal biological questions, making the timelines for accepted answers slower than capability growth alone might suggest. Finally, there is a strong risk of human preemption, as human-led research teams remain highly active across all these domains.
Anesthesia (18%) and Non-coding Genome (16%)
If an AI does answer one of these first, the mechanism of general anesthesia and the function of the non-coding genome are the strongest candidates. Anesthesia benefits from fast experimental feedback loops with controllable, measurable transitions. Recent human-led work using cortical assembloids and macaque studies https://www.cell.com/cell-reports/fulltext/S2211-1247%2826%2900126-9 Stem cell-derived brain models offer a new window into ... demonstrates that tractable perturbation systems exist, offering a promising setting for an AI agent to identify an accepted unifying mechanism. The non-coding genome is similarly attractive because it is highly scalable and data-heavy. Tools like the AlphaGenome Atlas (Sept 2026) already predict variant effects AlphaGenome Atlas: in silico mutagenesis of the entire ... AlphaGenome Atlas: in silico mutagenesis of the entire ..., but they count only as tools for a general agent here. The non-coding genome trails slightly behind anesthesia because it faces a higher risk of definitional disputes over what constitutes biological "function" versus junk DNA Non-coding DNA's Alpha Moment, whereas anesthesia has clearer mechanistic readouts.
Memory (11%) and Alzheimer's (9%)
How the brain stores long-term memories and the primary causal driver of Alzheimer's pose stiffer challenges. Memory storage has concrete mechanistic footholds, such as KIBRA–PKMζ modeling PKMζ-KIBRA interactions, molecular turnover, and memory and preserved synaptic architecture in hibernation https://www.science.org/doi/10.1126/science.aee7004, but translating these local findings into a generalized, brain-wide causal account is a massive leap. Alzheimer's research currently attracts immense funding and AI-hypothesis generation, such as Biomni-AD's target prioritization Mount Sinai Scientists Recognized With Global AI Prize for ... and Kosmos's flippase-gene findings Kosmos: An AI Scientist for Autonomous Discovery. However, resolution requires identifying the primary causal driver. Since Alzheimer's is likely multifactorial Refining, not abandoning, the amyloid hypothesis, establishing a single primary cause requires lengthy clinical validation, making a clear-cut AI-originated answer before 2040 much less likely.
Aging (6%)
The upstream molecular cause of aging is the least probable outcome. Like Alzheimer's, validation requires multi-year lifespan studies, severely capping the speed of iterative AI-led research. Furthermore, the premise of a single "upstream molecular cause" is deeply contested; recent cross-mammal studies and consensus at ARDD 2026 point toward modular architectures and multi-causal theories Universal transcriptomic hallmarks of mammalian ageing ... The evolution of aging research: from theories to ... ARDD 2026 Daily Recap. While general agents are generating early leads—such as Co-Scientist proposing metabolic regulation mechanisms https://deepmind.google/blog/opening-new-paths-in-aging-research/ and genetic factors https://deepmind.google/blog/fast-tracking-genetic-leads-to-reverse-cellular-aging/—the biological reality likely precludes a single upstream answer, rendering the question uniquely difficult to resolve as specified.
The probability of "None by 2040" was slightly increased to reflect the slower, unified timelines for breakthrough consensus across the cluster, acknowledging the difficulty of resolving multi-causal biological questions.
Ask a followup
Sign in to run · $20 free credit, no card · every claim cited